Morphic Holding, Inc. - Common Stock (NQ:MORF)

56.99 UNCHANGED

Last Price Updated: 4:00 PM EDT, Aug 15, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Morphic Holding, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Corning Increases Sales Forecast, Joins Morphic Holding, Lucid Group And Other Big Stocks Moving Higher On Monday ↗

July 08, 2024

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Morphic Holding, Inc. (Nasdaq - MORF), Desktop Metal, Inc. (NYSE - DM), Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR)

July 08, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

Dow Jumps Over 200 Points; Greenbrier Shares Fall After Q3 Results ↗

July 08, 2024

Via Benzinga

Topics Stocks

Recap: Morphic Holding Q4 Earnings ↗

February 22, 2024

Via Benzinga

Eli Lilly's First Biotech Deal Of 2024, Buys Chronic Disease Player Morphic For $3.2B ↗

July 08, 2024

Eli Lilly to acquire Morphic Holding Inc for $3.2 billion, strengthening its portfolio in chronic disease treatments. Morphic's lead program, MORF-057, targets inflammatory bowel disease, with...

Via Benzinga

Eli Lilly Snaps Up Morphic At 79% Premium ↗

July 08, 2024

Eli Lilly said Monday it would pay $3.2 billion to acquire an innovator in oral treatments for chronic bowel diseases.

Via Investor's Business Daily

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

July 08, 2024

It's time to start the week with a breakdown of the biggest pre-market stock movers traders will want to know about on Monday!

Via InvestorPlace

MORF Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Morphic Holding, Inc. Is Fair to Shareholders

July 08, 2024

From Halper Sadeh LLC

Via Business Wire

Morphic to Participate in Jefferies Global Healthcare Conference

May 31, 2024

From Morphic Therapeutic

Via GlobeNewswire

Morphic Demonstrates Novel Real-Time Visualization of Small Molecule α4β7 Inhibition of Gut-Trafficking Cells

May 21, 2024

From Morphic Therapeutic

Via GlobeNewswire

Morphic to Participate in RBC Capital Markets Global Healthcare Conference

May 09, 2024

From Morphic Therapeutic

Via GlobeNewswire

MORF Stock Earnings: Morphic Holding Beats EPS for Q1 2024 ↗

April 25, 2024

MORF stock results show that Morphic Holding beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024

April 25, 2024

From Morphic Therapeutic

Via GlobeNewswire

Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

April 02, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

March 26, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

MORF Investor Notice: Abraham, Fruchter & Twersky, LLP Investigating Claims on Behalf of Investors of Morphic Holding, Inc. (NASDAQ:MORF)

March 20, 2024

From Abraham, Fruchter & Twersky, LLP

Via GlobeNewswire

Morphic Appoints Dr. Simon Cooper as Chief Medical Officer

March 19, 2024

Experienced Clinical Development Leader with Deep Experience in Immunology and Inflammatory Diseases

From Morphic Therapeutic

Via GlobeNewswire

Morphic to Participate in March Investor Conferences

March 05, 2024

From Morphic Therapeutic

Via GlobeNewswire

Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023

February 22, 2024

From Morphic Therapeutic

Via GlobeNewswire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors

January 11, 2024

From Law Offices of Howard G. Smith

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors

January 10, 2024

From Glancy Prongay & Murray LLP

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors

January 04, 2024

From The Law Offices of Frank R. Cruz

Via Business Wire

Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 03, 2024

From Morphic Therapeutic

Via GlobeNewswire

Robbins LLP Reminds MORF Investors that it is Investigating Morphic Holdings, Inc. on Behalf of Investors

December 01, 2023

From Robbins LLP

Via Business Wire

Morphic Holding, Inc. Reminder: Robbins LLP is Investigating MORF on Behalf of Investors

November 22, 2023

From Robbins LLP

Via Business Wire

Morphic to Present at November Investor Conferences

November 10, 2023

From Morphic Therapeutic

Via GlobeNewswire

Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023

November 03, 2023

From Morphic Therapeutic

Via GlobeNewswire

NASDAQ: MORF Investor Notice: Investigation over Possible Securities Laws Violations by Morphic Holding, Inc. ↗

November 01, 2023

San Diego, CA -- (SBWIRE) -- 11/01/2023 -- Morphic Holding, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

Morphic Holding Investigation: Johnson Fistel Encourages Shareholders with Losses to Contact the Firm Regarding Investigation

October 21, 2023

From Johnson Fistel, LLP

Via Business Wire

Morphic Holding SHAREHOLDER ALERT: Johnson Fistel Encourages Morphic Holding Shareholders with Losses to Contact the Firm Regarding Investigation

October 14, 2023

From Johnson Fistel, LLP

Via Business Wire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.